228 related articles for article (PubMed ID: 25007795)
1. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils.
Eltboli O; Bafadhel M; Hollins F; Wright A; Hargadon B; Kulkarni N; Brightling C
BMC Pulm Med; 2014 Jul; 14():112. PubMed ID: 25007795
[TBL] [Abstract][Full Text] [Related]
2. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
[TBL] [Abstract][Full Text] [Related]
3. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
[TBL] [Abstract][Full Text] [Related]
6. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.
Soter S; Barta I; Antus B
Inflammation; 2013 Oct; 36(5):1178-85. PubMed ID: 23681903
[TBL] [Abstract][Full Text] [Related]
7. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
Gao J; Chen B; Wu S; Wu F
BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
[TBL] [Abstract][Full Text] [Related]
8. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
Pignatti P; Visca D; Zappa M; Zampogna E; Saderi L; Sotgiu G; Centis R; Migliori GB; Spanevello A
BMC Pulm Med; 2024 May; 24(1):247. PubMed ID: 38764008
[TBL] [Abstract][Full Text] [Related]
9. Post-bronchodilator Reversibility of FEV
Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
[TBL] [Abstract][Full Text] [Related]
10. Impaired macrophage phagocytosis in non-eosinophilic asthma.
Simpson JL; Gibson PG; Yang IA; Upham J; James A; Reynolds PN; Hodge S;
Clin Exp Allergy; 2013 Jan; 43(1):29-35. PubMed ID: 23278878
[TBL] [Abstract][Full Text] [Related]
11. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC
Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799
[TBL] [Abstract][Full Text] [Related]
12. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
[TBL] [Abstract][Full Text] [Related]
13. Blood and sputum eosinophils in COPD; relationship with bacterial load.
Kolsum U; Donaldson GC; Singh R; Barker BL; Gupta V; George L; Webb AJ; Thurston S; Brookes AJ; McHugh TD; Wedzicha JA; Brightling CE; Singh D
Respir Res; 2017 May; 18(1):88. PubMed ID: 28482840
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of eosinophilic asthma exacerbations.
Bjerregaard A; Laing IA; Backer V; Fally M; Khoo SK; Chidlow G; Sikazwe C; Smith DW; Le Souëf P; Porsbjerg C
Respirology; 2017 Feb; 22(2):295-300. PubMed ID: 27649851
[TBL] [Abstract][Full Text] [Related]
16. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
[TBL] [Abstract][Full Text] [Related]
17. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
Couillard S; Larivée P; Courteau J; Vanasse A
Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
[TBL] [Abstract][Full Text] [Related]
18. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.
Zhang J; Wang X; Chen Y; Yao W
Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
20. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
